Talking to My Partners About PrEP: Factors Associated with PrEP-Related Communication in a Longitudinal US Study of Sexual Minority Men Living with HIV

Prev Sci. 2022 Nov;23(8):1438-1447. doi: 10.1007/s11121-022-01372-6. Epub 2022 May 7.

Abstract

Treatment as prevention and pre-exposure prophylaxis (PrEP) have reduced HIV transmission among sexual minority men (SMM). However, little is known about PrEP-related communication in serodiscordant partnerships. In 2015-2016, 965 US SMM living with HIV (Mage = 39; 63% White, 19% Black, 18% Latinx) enrolled in a year-long longitudinal study with surveys every 3 months (2,850 surveys). Multilevel models explored factors associated with PrEP-related communication with HIV-negative partners. Most participants (77%) reported PrEP-related communication. Participants were more likely to discuss PrEP during periods with more sexual partners, AOR = 2.89, p < .001, and group sex, AOR = 1.99, p = .001. Those with more partners on average, β = 0.48, p < .001, and those engaging in other drug use more frequently, β = 0.11, p = .002, were more likely to discuss PrEP. PrEP-related communication was more common for men who disclosed their HIV status, β = 0.22, p < .001, and who had undetectable viral loads, β = 0.25, p = .007. Communication was also more common for those with higher incomes, β = 0.12, p = .02, and from larger cities, β = 0.07, p = .048, and less common for Black participants, β = - 0.29, p = .003, and older participants, β = - 0.18, p < .001. PrEP-related communication increased over the course of the study, AOR = 1.16, p= .02. PrEP can confer additional HIV prevention benefits within serodiscordant partnerships, and future research should continue to explore the role PrEP plays in these partnerships.

Keywords: Multilevel modeling; People living with HIV; Pre-exposure prophylaxis; Safer sex communication; Serodiscordant partnerships; Sexual minority men.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Communication
  • HIV Infections* / drug therapy
  • Homosexuality, Male
  • Humans
  • Longitudinal Studies
  • Male
  • Sexual Behavior
  • Sexual Partners
  • Sexual and Gender Minorities*